News

Major Depressive Disorder Pipeline Appears Robust With 75+ Key Companies Actively Working In The Therapeutics Segment Delveinsight
DelveInsight's Major Depressive Disorder pipeline report depicts a robust space with 75+ active players working to develop ...
C&EN4d
Identification of an Inhibitory Alcohol Binding Site in GABA A ρ1 Receptors
Alcohols inhibit γ-aminobutyric acid type A ρ1 receptor function. After introducing mutations in several positions of the second transmembrane helix in ρ1, we studied the effects of ethanol and ...
ascopubs.org4d
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation–Positive Non–Small ...
A total of 73 patients diagnosed with LM were treated with osimertinib, including 64 patients evaluable for the LM efficacy set—T790M negative (n = 62) and T790M positive (n = 2). The median OS in the ...
C&EN5d
Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB
Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, Rockville, Maryland 20852, United ...